REATA PHARMACEUTICALS INC's ticker is RETA and the CUSIP is 75615P103. A total of 209 filers reported holding REATA PHARMACEUTICALS INC in Q1 2023. The put-call ratio across all filers is 0.53 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $2,263,512 | -31.7% | 22,200 | -39.1% | 0.05% | -26.5% |
| Q1 2023 | $3,314,398 | +135.8% | 36,454 | -1.5% | 0.07% | +106.1% |
| Q4 2022 | $1,405,630 | +201.0% | 37,000 | +98.9% | 0.03% | +175.0% |
| Q3 2022 | $467,000 | -25.0% | 18,600 | -9.3% | 0.01% | -25.0% |
| Q2 2022 | $623,000 | -78.2% | 20,500 | -76.5% | 0.02% | -76.1% |
| Q1 2022 | $2,856,000 | +239.6% | 87,164 | +173.2% | 0.07% | +235.0% |
| Q4 2021 | $841,000 | -85.7% | 31,900 | -45.5% | 0.02% | -87.7% |
| Q3 2021 | $5,886,000 | +110.1% | 58,500 | +195.5% | 0.16% | +80.0% |
| Q2 2021 | $2,802,000 | +746.5% | 19,800 | +638.8% | 0.09% | +650.0% |
| Q4 2020 | $331,000 | – | 2,680 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Conrad N. Hilton Foundation | 63,481 | $7,847,000 | 100.00% |
| CPMG Inc | 2,896,901 | $358,115,000 | 55.16% |
| PARAGON ASSOCIATES & PARAGON ASSOCIATES II JOINT VENTURE | 140,000 | $17,307,000 | 26.62% |
| Corriente Advisors, LLC | 525,000 | $64,901,000 | 15.45% |
| DUMAC, INC. | 76,050 | $9,401,000 | 7.33% |
| MADDEN SECURITIES Corp | 35,152 | $4,345,000 | 2.80% |
| Biondo Investment Advisors, LLC | 113,692 | $14,055,000 | 2.69% |
| Duquesne Family Office | 749,897 | $92,702,000 | 2.50% |
| LBJ Family Wealth Advisors, Ltd. | 30,368 | $3,754,000 | 2.44% |
| Integral Health Asset Management, LLC | 50,000 | $6,181,000 | 1.84% |